Radiomics in Cancer Care: Breaking Down the Evidence Behind the Buzz

Radiomics in Cancer Care: Breaking Down the Evidence Behind the Buzz   Introduction Radiomics represents a rapidly advancing field within oncology that extracts high-dimensional quantitative data from medical imaging, offering the potential to transform cancer diagnosis, prognosis, and treatment strategies. This emerging discipline is built

Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond

Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond   Check back later for a possible video summary. Videos are created for most articles.   Abstract This paper provides an in-depth review of monoclonal antibody (mAb) therapies in the treatment of relapsed multiple myeloma (MM), with a particular focus on bispecific antibodies

Gliomas And Mental Health Issues

Gliomas And Mental Health Issues Overview Approximately one-third of adults with cancer experience common mental health disorders alongside their primary malignancy. However, it is not well understood whether this prevalence is similar in patients with brain tumors or what factors contribute to the risk of psychiatric comorbidities in this group.

Bimekizumab Proves To Be A Highly Effective Therapy For Psoriatic Arthritis Patients

Bimekizumab Proves To Be A Highly Effective Therapy For Psoriatic Arthritis Patients Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting joints, skin, nails, and other tissues. Because it is long-term and can vary significantly between patients, ongoing treatment is needed. Biologic therapies like TNF inhibitors (TNFi) are often combined with

Pancreatic Cancer Patients Discover Weight Measurements Can Be Deceptive

Pancreatic Cancer Patients Discover Weight Measurements Can Be Deceptive Overview Elevated body mass index (BMI) has been associated with an increased risk of pancreatic cancer (PC). However, cancer-associated weight loss occurring years before diagnosis may have led to an underestimation of this association. The extent to which this potential bias has been

Radiomics in Cancer Care: Breaking Down the Evidence Behind the Buzz